Cargando…

Enhancement of chemotherapy by manipulation of tumour pH

The extracellular (interstitial) pH (pHe) of solid tumours is significantly more acidic compared to normal tissues. In-vitro, low pH reduces the uptake of weakly basic chemotherapeutic drugs and, hence, reduces their cytotoxicity. This phenomenon has been postulated to contribute to a ‘physiological...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghunand, N, He, X, Sluis, R van, Mahoney, B, Baggett, B, Taylor, C W, Paine-Murrieta, G, Roe, D, Bhujwalla, Z M, Gillies, R J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363059/
https://www.ncbi.nlm.nih.gov/pubmed/10362108
http://dx.doi.org/10.1038/sj.bjc.6690455
_version_ 1782153609554690048
author Raghunand, N
He, X
Sluis, R van
Mahoney, B
Baggett, B
Taylor, C W
Paine-Murrieta, G
Roe, D
Bhujwalla, Z M
Gillies, R J
author_facet Raghunand, N
He, X
Sluis, R van
Mahoney, B
Baggett, B
Taylor, C W
Paine-Murrieta, G
Roe, D
Bhujwalla, Z M
Gillies, R J
author_sort Raghunand, N
collection PubMed
description The extracellular (interstitial) pH (pHe) of solid tumours is significantly more acidic compared to normal tissues. In-vitro, low pH reduces the uptake of weakly basic chemotherapeutic drugs and, hence, reduces their cytotoxicity. This phenomenon has been postulated to contribute to a ‘physiological’ resistance to weakly basic drugs in vivo. Doxorubicin is a weak base chemotherapeutic agent that is commonly used in combination chemotherapy to clinically treat breast cancers. This report demonstrates that MCF-7 human breast cancer cells in vitro are more susceptible to doxorubicin toxicity at pH 7.4, compared to pH 6.8. Furthermore (31)P-magnetic resonance spectroscopy (MRS) has shown that the pHe of MCF-7 human breast cancer xenografts can be effectively and significantly raised with sodium bicarbonate in drinking water. The bicarbonate-induced extracellular alkalinization leads to significant improvements in the therapeutic effectiveness of doxorubicin against MCF-7 xenografts in vivo. Although physiological resistance to weakly basic chemotherapeutics is well-documented in vitro and in theory, these data represent the first in vivo demonstration of this important phenomenon. © 1999 Cancer Research Campaign
format Text
id pubmed-2363059
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23630592009-09-10 Enhancement of chemotherapy by manipulation of tumour pH Raghunand, N He, X Sluis, R van Mahoney, B Baggett, B Taylor, C W Paine-Murrieta, G Roe, D Bhujwalla, Z M Gillies, R J Br J Cancer Regular Article The extracellular (interstitial) pH (pHe) of solid tumours is significantly more acidic compared to normal tissues. In-vitro, low pH reduces the uptake of weakly basic chemotherapeutic drugs and, hence, reduces their cytotoxicity. This phenomenon has been postulated to contribute to a ‘physiological’ resistance to weakly basic drugs in vivo. Doxorubicin is a weak base chemotherapeutic agent that is commonly used in combination chemotherapy to clinically treat breast cancers. This report demonstrates that MCF-7 human breast cancer cells in vitro are more susceptible to doxorubicin toxicity at pH 7.4, compared to pH 6.8. Furthermore (31)P-magnetic resonance spectroscopy (MRS) has shown that the pHe of MCF-7 human breast cancer xenografts can be effectively and significantly raised with sodium bicarbonate in drinking water. The bicarbonate-induced extracellular alkalinization leads to significant improvements in the therapeutic effectiveness of doxorubicin against MCF-7 xenografts in vivo. Although physiological resistance to weakly basic chemotherapeutics is well-documented in vitro and in theory, these data represent the first in vivo demonstration of this important phenomenon. © 1999 Cancer Research Campaign Nature Publishing Group 1999-06 /pmc/articles/PMC2363059/ /pubmed/10362108 http://dx.doi.org/10.1038/sj.bjc.6690455 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Raghunand, N
He, X
Sluis, R van
Mahoney, B
Baggett, B
Taylor, C W
Paine-Murrieta, G
Roe, D
Bhujwalla, Z M
Gillies, R J
Enhancement of chemotherapy by manipulation of tumour pH
title Enhancement of chemotherapy by manipulation of tumour pH
title_full Enhancement of chemotherapy by manipulation of tumour pH
title_fullStr Enhancement of chemotherapy by manipulation of tumour pH
title_full_unstemmed Enhancement of chemotherapy by manipulation of tumour pH
title_short Enhancement of chemotherapy by manipulation of tumour pH
title_sort enhancement of chemotherapy by manipulation of tumour ph
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363059/
https://www.ncbi.nlm.nih.gov/pubmed/10362108
http://dx.doi.org/10.1038/sj.bjc.6690455
work_keys_str_mv AT raghunandn enhancementofchemotherapybymanipulationoftumourph
AT hex enhancementofchemotherapybymanipulationoftumourph
AT sluisrvan enhancementofchemotherapybymanipulationoftumourph
AT mahoneyb enhancementofchemotherapybymanipulationoftumourph
AT baggettb enhancementofchemotherapybymanipulationoftumourph
AT taylorcw enhancementofchemotherapybymanipulationoftumourph
AT painemurrietag enhancementofchemotherapybymanipulationoftumourph
AT roed enhancementofchemotherapybymanipulationoftumourph
AT bhujwallazm enhancementofchemotherapybymanipulationoftumourph
AT gilliesrj enhancementofchemotherapybymanipulationoftumourph